VEGFA and diabetic retinopathy: Additionally, scutellarin was reported to inhibit hypoxia-induced and high glucose-induced proliferation and vascular endothelial growth factor (VEGF) expression in human retinal endothelial cells (HRECs), suggesting that it might be a potential therapy for diabetic retinopathy [7].